ONCO-GENOMICS SERVICES


Next Generation Sequencing (NGS) Services, we utilize a NextSeq550Dx for mid-throughput short read runs and a MiSeqDx for low-throughput rapid runs as well as for quality control and validation. We offer the Illumina TruSight Oncology 500 on our NextSeq550Dx platform, which is a comprehensive oncology panel that allows for the analysis of multiple variant types and key biomarkers in 500+ genes across DNA and RNA in a single assay.


Titre du document

LABORATORY SERVICES


PreCheck Health provides a clear pathway for rapid treatment of infectious disease by utilizing CoPrimers™ a leading-edge, patented platform technology developed by Co-Diagnostics that dramatically enhances the output of molecular diagnostic tests conducted via real-time polymerase chain reaction (“PCR”) tests.




Titre du document

  • At PreCheck Health Services, patient health is our highest priority. Early disease detection and prevention comprise the core of our services. PreCheck Health Services has integrated a full platform for diagnostic services for private and public health, which not only offers products for disease prevention, but also an in-house high complexity molecular testing laboratory.

    PreCheck Health Laboratory is a state-of-the-art laboratory that utilizes the latest technologies for a wide array of assays. In brief, our CLIA certified and CAP accredited laboratory employs the use of Real-Time qPCR for molecular disease diagnostics and Next Generation Sequencing (NGS) for molecular pan-cancer profiling and characterization of somatic mutations in cancer, regardless of tumor origin. In addition to somatic mutations, we also focus on germline mutations, such as hereditary cancers, cardiovascular disease, cystic fibrosis, and immunodeficiencies.

    CLIA Certified ID No. 10D2210020

  • CAP Accredited No. 9101993
  • At PreCheck Health Services, patient health is our highest priority. Early disease detection and prevention comprise the core of our services. PreCheck Health Services has integrated a full platform for diagnostic services for private and public health, which not only offers products for disease prevention, but also an in-house high complexity molecular testing laboratory.

    PreCheck Health Laboratory is a state-of-the-art laboratory that utilizes the latest technologies for a wide array of assays. In brief, our CLIA certified and CAP accredited laboratory employs the use of Real-Time qPCR for molecular disease diagnostics and Next Generation Sequencing (NGS) for molecular pan-cancer profiling and characterization of somatic mutations in cancer, regardless of tumor origin. In addition to somatic mutations, we also focus on germline mutations, such as hereditary cancers, cardiovascular disease, cystic fibrosis, and immunodeficiencies.

    CLIA Certified ID No. 10D2210020

  • CAP Accredited No. 9101993
Precheck health